Metformin Generics Are "Approvable"; Barr Says Delay Helps Other Generics

The delay in FDA approval of generic versions of Bristol-Myers Squibb's Glucophage (metformin) will reduce Barr's profitability from the product by giving other generic companies time to increase their manufacturing capacity, Barr said.